White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
White Matter Hyperintensities (WMHs) are associated with cognitive decline in aging and Alzheimer's disease. However, the pathogenesis of cognitive decline in Parkinson's disease (PD) is not as clearly related to vascular causes, and therefore the role of WMHs as a marker of small-vessel d...
Main Authors: | Mahsa Dadar, Yashar Zeighami, Yvonne Yau, Seyed-Mohammad Fereshtehnejad, Josefina Maranzano, Ronald B. Postuma, Alain Dagher, D. Louis Collins |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | NeuroImage: Clinical |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158218303000 |
Similar Items
-
Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
by: Yashar Zeighami, et al.
Published: (2019-01-01) -
Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
by: Nooshin Abbasi, et al.
Published: (2020-01-01) -
Network structure of brain atrophy in de novo Parkinson's disease
by: Yashar Zeighami, et al.
Published: (2015-09-01) -
Testing the Protein Propagation Hypothesis of Parkinson Disease
by: Alain Dagher, et al.
Published: (2018-07-01) -
Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging
by: Mahsa Dadar, et al.
Published: (2017-08-01)